Comprehensive analysis of Belgium's in vitro diagnostics market

20. November 2009 03:42

Research and Markets (http://www.researchandmarkets.com/research/1a7472/belgium_in_vitro_d) has announced the addition of Global Markets Direct's new report "Belgium In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015" to their offering. [More]

f995c247-2a3f-4a5a-96b7-2d12577cda25|0|.0

Posted in: Device / Technology News

Tags: Cytology, Immunology, Investment

Complete analysis of in vitro diagnostics market in Korea

20. November 2009 02:31

Research and Markets (http://www.researchandmarkets.com/research/1ae759/republic_of_korea) has announced the addition of Global Markets Direct's new report "Republic of Korea In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015" to their offering. [More]

68d61d06-8610-448e-8e1a-919ada0f8f7e|0|.0

Posted in: Device / Technology News

Tags: Cytology, Immunology, Investment

Predictive Biosciences commences clinical trials of its bladder cancer assay

4. November 2009 03:38

Predictive Biosciences Inc. today announced the publication of pilot study results in the November issue of the Journal of Urology, highlighting the Company’s novel urinary biomarker approach to bladder cancer detection that achieves exceptionally high Negative and Positive Predictive Values (NPV and PPV). [More]

c0cffc02-2011-4bd9-9941-c19cd5719b1d|0|.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Biomarker, Bladder Cancer, Cancer, Cystoscopy, Cytology, Urology

Biomoda receives U.S patent for cytology-based screening assay

3. November 2009 23:45

Biomoda, Inc. (OTCBB: BMOD), an Albuquerque-based cancer diagnostics company, announces that it has received notice of allowance for a U.S. Patent protecting the proprietary formula for the composition that binds to cancer cells which is utilized in Biomoda’s screening assay for the early detection of cancer [More]

0838b3b4-0c70-41e7-ba26-c869b00bb8ee|0|.0

Posted in: Device / Technology News | Medical Patent News

Tags: Cancer, Cytology, Lung Cancer

Biomoda to launch multisite Phase III clinical trials of CyPath assay

29. October 2009 00:59

Medical diagnostics company Biomoda, Inc. is taking preliminary steps to launch multisite Phase III clinical trials of its in-vitro diagnostic for early-stage lung cancer, trademarked under the name CyPath®. [More]

bc36efb7-982f-422c-8300-c54104daef05|0|.0

Posted in: Device / Technology News | Medical Condition News

Tags: Cancer, Cytology, Health and Human Services, Lung Cancer

Liquid-based cytology is not better than Pap tests for detecting cervical cancer

28. October 2009 00:43

A Dutch study that included nearly 90,000 women finds that liquid-based cytology, a commonly used alternative to conventional Pap tests, is not superior to Pap tests for the detection of cervical cancer precursors or cancer, according to a study in the October 28 issue of JAMA. [More]

f5438bf9-f7b5-44df-90f6-a7cd5d80b65c|0|.0

Posted in: Medical Condition News | Women's Health News

Tags: Cancer, Cervical Cancer, Cervical Intraepithelial Neoplasia, Cytology, Pap Smear

NCI and NIOH to purchase additional MammoView line of surgical endoscopy instruments

24. October 2009 03:10

Solos Endoscopy, Inc. is pleased to announce that the Company has received additional purchase orders for its MammoView(TM) line of surgical endoscopy instruments from the National Cancer Institute (NCI), as well as the U.S. National Institute of Health (NIOH), which is part of the U.S. Department of Health and Human Services. [More]

7f298b01-faef-43b4-a809-ad217b4b5ed7|0|.0

Posted in: Business / Finance | Device / Technology News

Tags: Cancer, Cell, Cytology, Health and Human Services, Hospital

NCCN updates NCCN Clinical Practice Guidelines in Oncology for Cervical Cancer Screening

15. October 2009 04:46

The National Comprehensive Cancer Network (NCCN) recently made updates to the NCCN Clinical Practice Guidelines in Oncology(TM) for Cervical Cancer Screening that include a new section providing recommendations for women who have positive results for the HPV High Risk DNA test but negative cervical cytology screen/Pap smears. [More]

28b1c872-78ba-4f0c-98eb-12a9ebc3b5af|0|.0

Posted in: Device / Technology News | Medical Condition News

Tags: Cancer, Cervical Cancer, Cytology, DNA, Hospital, Oncology, Pap Smear, Stress, Vaccine

Spectrascience receives Japanese patent for its Optical Biopsy Forceps System and Method of Sampling Tissue

8. October 2009 05:25

SpectraScience, Inc., a San Diego based medical device company, today announced that it has been awarded Japanese Patent number 4361683 for its Optical Biopsy Forceps System and Method of Sampling Tissue. [More]

83d415e8-587c-4bec-846c-72dcc2fc64aa|0|.0

Posted in: Medical Patent News

Tags: Barrett's Esophagus, Biopsy, Cancer, Cervical Cancer, Cytology

mtm laboratories signs additional tranche of Euro 7 million to its Series C funding

6. October 2009 07:34

mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, today announced the signing for an additional tranche of Euro 7 million to its Series C funding. This addition is a formal expansion of the Company’s last Series C in March 2008 and increases the total for the round to Euro 39 million (USD 57 million) in equity. [More]

c89e3d1b-f7df-4470-a2ff-8577576ca1c6|0|.0

Posted in: Business / Finance

Tags: Biomarker, Cancer, Cervical Cancer, Cytology

Reportlinker's medical review criteria guidelines for managing care

30. September 2009 08:03

Reportlinker Adds Medical Review Criteria Guidelines for Managing Care (8th ed. - 2009) [More]

8df1ed87-8391-4b34-bf59-57c82f4b06c0|0|.0

Posted in: Healthcare News

Tags: Acne, Acupuncture, Allergy, Alopecia, Alternative Medicine, Analgesia, Anesthesiology, Angina, Angioplasty, Antibody, Aortic Aneurysm, Appendectomy, Asthma, Atopic Dermatitis, Atrial Fibrillation, Autism, Back Pain, Balloon Angioplasty, Bariatric Surgery, Barrett's Esophagus, Basal Cell Carcinoma, Biopsy, Blood Pressure, Bone, Bone Marrow, Brachytherapy, Brain, Breast Cancer, Burn, Calcium, Cancer, Cardiology, Cardiomyopathy, Cartilage, Catheter, Catheter Ablation, Celiac Disease, Cell, Cellulitis, Cerebral Palsy, Chemotherapy, Cholesterol, Cleft Palate, Collagen, Colon Cancer, Colonoscopy, Colorectal Cancer, Congestive Heart Failure, Coronary Artery Disease, Cystic Fibrosis, Cytology, Dandruff, Defibrillator, Dendritic Cell, Dermatitis, Dermatology, Diabetes, Diabetes Mellitus, Diabetic Neuropathy, Dialysis, Diet, DNA, Dysplasia, Dystonia, Education, Epidural, Etanercept, Exercise, Fibrosis, Gastroenterology, Gene Expression, Gonadotropin, Headache, Hearing Loss, Heart Failure, Hematology, Hemophilia, Hepatitis B, Herpes, Herpes Zoster, Histamine, Homeopathy, Hospital, Hypersensitivity, Hypoglycemia, Hypothermia, Immunization, Immunotherapy, Impetigo, Implants, Incontinence, Inflammatory Bowel Disease, Infliximab, Influenza, Insulin, Interleukin-2, Kinesiology, Light Therapy, Lung Cancer, Lyme Disease, Lymphedema, Macrophage, Mastectomy, Medicare, Meditation, Melanoma, Meniere's Disease, Metastasis, Microscopy, Migraine, Monoclonal Antibody, Mozobil, Nephrology, Nervous System, Neuralgia, Neuroimaging, Neurology, Neuropathy, Neurosurgery, Nuclear Medicine, Nursing, Nutrition, Obesity, Obstructive Sleep Apnea, Oncology, Osteoarthritis, Osteonecrosis, Otitis Media, Ovarian Cancer, Oxygen Therapy, Palliative Care, Paralysis, Photodynamic Therapy, Plastic Surgery, Prosthetic, Psoriasis, Radiofrequency Ablation, Renal Failure, Rhinitis, Rosacea, Scabies, Schizophrenia, Scleroderma, Scoliosis, Sexual Dysfunction, Sigmoidoscopy, Sinusitis, Sleep, Sleep Apnea, Smoking, Smoking Cessation, Speech, Squamous Cell Carcinoma, Stem Cell, Stenosis, Stent, Stress, Stroke, Tinnitus, Tonsillectomy, Transplant, Ultrasound, Urinary Incontinence, Ventilator, Vitiligo, Wound Healing, Yoga

Hologic's ThinPrep integrated imager receives CE marking approval

30. September 2009 07:34

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced it has received CE marking approval for its ThinPrep® integrated imager. [More]

9ead22f4-9102-4c67-aef4-df801acc4122|0|.0

Posted in: Device / Technology News

Tags: Biopsy, Breast Cancer, Cancer, Cell, Cervical Cancer, Contraception, Cytology, DNA, Mammography, Osteoporosis

Impact of the economic downturn on in vitro diagnostic companies

25. September 2009 09:57

It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information's lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen's new report In Vitro Diagnostics in a Recession. [More]

59d88df3-cac6-4952-91e6-b34b72b0821b|0|.0

Posted in: Device / Technology News

Tags: Creatinine, Cytology, Diabetes, Flow Cytometry, Genetics, Hematology, Hospital, Stress

Report on a recent survey conducted on diagnostic labs

25. September 2009 06:43

From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information presents the summarized results from a recent survey of a critical mass of diagnostic labs in the U.S, with analysis from Kalorama's leading diagnostic analyst, Shara Rosen. [More]

6c6cd5bc-cc30-4c27-8e38-6a070e903afd|0|.0

Posted in: Healthcare News

Tags: Adenovirus, Bladder Cancer, Cancer, Chlamydia, Communicable Disease, Cystic Fibrosis, Cytology, Cytomegalovirus, DNA, Epstein-Barr Virus, Evolution, Fibrosis, Fragile X Syndrome, Genetics, Gonorrhea, Hematology, Hepatitis B, Hepatitis C, Herpes, Herpes Simplex, Hospital, Immunology, Influenza, Intensive Care, Oncology, Pathology, Staphylococcus aureus, Transplant, Tuberculosis, Virus

HPV screening and vaccination programmes could eradicate cervical cancer

24. September 2009 06:09

Cervical cancer could be eradicated within the next 50 years if countries implement national screening programmes based on detection of the human papilloma virus (HPV), which causes the disease, together with vaccination programmes against the virus, according to a cervical cancer screening expert. [More]

4e3cca52-728b-4703-9f7b-4bc1693f352a|0|.0

Posted in: Medical Condition News | Women's Health News

Tags: Cancer, Cervical Cancer, Cytology, Education, Pap Smear, Vaccine, Virus

Free!

Recent Comments

Twitter

Information

Cytology News and Research

Comprehensive analysis of Belgium's in vitro diagnostics market

Complete analysis of in vitro diagnostics market in Korea

Predictive Biosciences commences clinical trials of its bladder cancer assay

Biomoda receives U.S patent for cytology-based screening assay

Biomoda to launch multisite Phase III clinical trials of CyPath assay

Liquid-based cytology is not better than Pap tests for detecting cervical cancer

NCI and NIOH to purchase additional MammoView line of surgical endoscopy instruments

NCCN updates NCCN Clinical Practice Guidelines in Oncology for Cervical Cancer Screening

Spectrascience receives Japanese patent for its Optical Biopsy Forceps System and Method of Sampling Tissue

mtm laboratories signs additional tranche of Euro 7 million to its Series C funding

Reportlinker's medical review criteria guidelines for managing care

Hologic's ThinPrep integrated imager receives CE marking approval

Impact of the economic downturn on in vitro diagnostic companies

Report on a recent survey conducted on diagnostic labs

HPV screening and vaccination programmes could eradicate cervical cancer

Recent Articles

Free!

Recent Comments

Twitter

Information

Cytology News and Research

Medical News Cloud

Recent Articles